WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced the first 80 companies selected through a competitive screening process to present at the Eleventh Annual BIO® CEO & Investor Conference. Presenting companies were selected for their potential to deliver on near-term clinical catalysts and accomplishments across major therapeutic markets and areas of unmet medical need.
